Medicare Enrolled
Dr. Jose Aristizabal, MD
Pulmonary Disease · Decatur, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aristizabal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aristizabal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aristizabal
Dr. Jose Aristizabal is a pulmonary disease specialist in Decatur, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Aristizabal performed 1,501 Medicare services across 1,182 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aristizabal received a total of $17,301 from 64 pharmaceutical and/or device companies across 935 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aristizabal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 28% volume in GA
$17,301 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,501
Medicare services
Top 28% in GA for pulmonary disease
1,182
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
351 | $97 | $387 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
266 | $31 | $130 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
252 | $34 | $131 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
251 | $44 | $170 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
200 | $136 | $541 |
| New patient office visit, complex (60-74 min) | 54 | $170 | $664 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
41 | $95 | $355 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
34 | $170 | $667 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $126 | $504 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
16 | $25 | $102 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
16 | $14 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,301
Total received (2018-2024)
Avg $2,472/year across 7 years
Top 13% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
935
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,232 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,733
2023
$1,957
2022
$3,009
2021
$2,651
2020
$2,264
2019
$3,316
2018
$2,371
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$230
GlaxoSmithKline, LLC.
$206
JAZZ PHARMACEUTICALS INC.
$122
Grifols USA, LLC
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
GENZYME CORPORATION
$88
Philips North America LLC
$88
Merck Sharp & Dohme LLC
$79
Insmed, Inc.
$78
Regeneron Healthcare Solutions, Inc.
$76
Actelion Pharmaceuticals US, Inc.
$58
Mylan Specialty L.P.
$57
Amgen Inc.
$56
Harmony Biosciences Llc
$52
United Therapeutics Corporation
$45
HARMONY BIOSCIENCES LLC
$44
INTUITIVE SURGICAL, INC.
$43
Paratek Pharmaceuticals, Inc.
$43
Baxter Healthcare
$35
Vifor Pharma, Inc.
$27
PFIZER INC.
$24
Resmed Corp
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
ANI Pharmaceuticals, Inc.
$17
Hikma Pharmaceuticals USA
$16
Electromed, Inc.
$14
Top 3 companies account for 32.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,895
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,231
AstraZeneca Pharmaceuticals LP
$1,826
Olympus Corporation of the Americas
$1,042
Actelion Pharmaceuticals US, Inc.
$974
United Therapeutics Corporation
$802
JAZZ PHARMACEUTICALS INC.
$647
Grifols USA, LLC
$596
Mylan Specialty L.P.
$505
Regeneron Healthcare Solutions, Inc.
$414
Harmony Biosciences LLC
$364
Insmed, Inc.
$337
Amgen Inc.
$304
Teva Pharmaceuticals USA, Inc.
$270
Daiichi Sankyo Inc.
$250
GENZYME CORPORATION
$246
Electromed, Inc.
$231
Mallinckrodt Hospital Products Inc.
$214
Sunovion Pharmaceuticals Inc.
$194
Philips Electronics North America Corporation
$188
Intuitive Surgical, Inc.
$186
Takeda Pharmaceuticals U.S.A., Inc.
$161
Paratek Pharmaceuticals, Inc.
$150
Advanced Respiratory, Inc
$149
Merck Sharp & Dohme LLC
$142
Circassia Pharmaceuticals Inc
$128
Genentech USA, Inc.
$118
Bayer HealthCare Pharmaceuticals Inc.
$113
HARMONY BIOSCIENCES LLC
$111
Jazz Pharmaceuticals Inc.
$106
Baxter Healthcare
$106
PFIZER INC.
$100
Philips North America LLC
$88
Gilead Sciences, Inc.
$87
Mallinckrodt LLC
$81
ANI Pharmaceuticals, Inc.
$77
Shire North American Group Inc
$65
Mallinckrodt Enterprises LLC
$58
Hikma Pharmaceuticals USA
$56
Janssen Pharmaceuticals, Inc
$55
Harmony Biosciences Llc
$52
UCB, Inc.
$49
INTUITIVE SURGICAL, INC.
$43
Allergan Inc.
$42
Vanda Pharmaceuticals Inc.
$42
ADVANCED RESPIRATORY, INC
$38
IDORSIA PHARMACEUTICALS US INC
$36
Axsome Therapeutics, Inc.
$29
Vifor Pharma, Inc.
$27
Vapotherm Inc
$25
ACADIA Pharmaceuticals Inc
$24
PORTOLA PHARMACEUTICALS, INC.
$23
Resmed Corp
$21
PORTOLA PHARMACEUTICALS, LLC
$21
Inogen, Inc.
$20
Covis Pharma GmBH
$19
Horizon Therapeutics plc
$18
Melinta Therapeutics, LLC
$17
Melinta Therapeutics, Inc.
$17
AbbVie Inc.
$17
Merck Sharp & Dohme Corporation
$17
Allergan, Inc.
$15
Veran Medical Technologies, Inc.
$13
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ALVESCO · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CINQAIR · DAYBUE · DS Cpap Auto Core · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · GLASSIA · HETLIOZ · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INJECTAFER · InogenOne · LONHALA MAGNAIR · NIOX VERO · NUCALA · NUZYRA · Neupro · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Olympus EBUS Bronchoscopes · PREVNAR 20 · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · QVAR · RAYOS · Respiratoriy Care Undiv · Rezzayo · Ryaltris · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vabomere · WAKIX · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XYREM · XYWAV · Xembify · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
131
Per 100K population
17.2
County median income
$77,683
Nearest hospital
EMORY DECATUR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aristizabal is a clinical cardiology specialist, with above-average Medicare volume (top 28% in GA), with low-engagement industry engagement in the top 13% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aristizabal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aristizabal performed 351 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aristizabal receive payments from pharmaceutical companies?
Yes. Dr. Aristizabal received a total of $17,301 from 64 companies across 935 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aristizabal's costs compare to other pulmonary diseases in Decatur?
Dr. Aristizabal's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aristizabal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Decatur
Browse pulmonary diseases in Decatur ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology